ArticlePharmaceutics2024

Enhancing Oral Delivery of Biologics: A Non-Competitive and Cross-Reactive Anti-Leptin Receptor Nanofitin Demonstrates a Gut-Crossing Capacity in an Ex Vivo Porcine Intestinal Model.

Solene Masloh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.